YOU ARE HERE: LAT HomeCollections

Octuplets draw critical eyes to fertility industry

Without much regulation or scrutiny from the government or insurance companies, the transfer of embryos is more like a private bargain between doctors and patients.

February 14, 2009|Alan Zarembo

When the identity of Nadya Suleman's fertility doctor was made public this week, the Internet lit up with angry commentary.

Many called for Dr. Michael Kamrava to be stripped of his medical license -- or worse -- for providing the fertility treatments that led to Suleman's 14 children, including last month's octuplets.

Rosalind Saxton had a different reaction.

"If anything, this incident has increased my confidence in the doctor," said the 41-year-old, who has been preparing to do in vitro fertilization with Kamrava since three other doctors turned her down, telling her to lose weight first.

Suleman "was successful," she said. "That would give anybody confidence."

Saxton's view contrasts sharply with that of fertility experts, who consider any pregnancy resulting in more than twins to be a poor outcome because of the danger it poses to the mother and babies.

Her view points to a key problem in fertility medicine: Treatment is a private bargain between doctor and patient, insulated from the outside world.

It escapes the scrutiny of insurance companies because most patients pay out of pocket. And it escapes government regulation largely because policymakers have been uncomfortable treading into the minefield of reproductive rights.

That makes the field ripe for periodic scandal and controversy: The 66-year-old woman who delivers twins, the doctor who steals eggs, the unwanted embryos in deep-freeze limbo.

The interests of fertility doctors and patients can converge with disturbing and even disastrous consequences that extend far beyond the people directly involved.

Patients, especially those with limited resources, may push for extreme treatments. And doctors, striving to succeed in a highly competitive field, may push the boundaries of good medical practice.

Children of "high-order" multiple births -- triplets and beyond -- usually arrive prematurely and are more likely to have developmental problems and disabilities.

Society can wind up bearing the cost, as in the case of Suleman's octuplets, whose care may be covered by Medi-Cal -- the state health plan for the poor -- and could cost taxpayers millions.

Kirk O. Hanson, an ethicist at Santa Clara University, said Suleman's case raises the issue of who should be allowed to have children and how many.

"We are loath to let the government have a say in this," he said, "but an incident like this inevitably forces us to ask whether in vitro fertilization should be regulated."

Suleman, 33, whose other six children are also products of in vitro fertilization, or IVF, receives food stamps. She told NBC news that in her most recent fertility treatment, she wanted all six of her remaining frozen embryos to be transferred into her to maximize her chance of another pregnancy.

Numerous fertility doctors said that so many embryos should never have been used for a woman her age. Professional guidelines suggest a maximum of two.

But all six embryos took, and two are thought to have split, bringing the number of fetuses to eight. She declined to undergo a procedure to reduce the number, which doctors often recommend in pregnancies involving three or more fetuses.

As news of the octuplets' birth led to public outcry, the Medical Board of California announced it had launched an investigation into the case.

Before the octuplets brought him unwanted prominence, Kamrava sought attention as a pioneer in his field.

On his website, on television and in interviews on local Persian radio, he promoted unconventional fertility methods that he said would boost the chances that embryos would take.

In fact, he was a small player in the crowded field of fertility medicine in Southern California. His success rate was among the lowest in the country, according to statistics collected by the federal government. In the last five years for which data is available, only 30 of the 355 IVF procedures he performed resulted in live births.

At the same time, he was using more embryos per try than the vast majority of clinics nationwide, according to the statistics. Outside experts said the numbers suggested problems with his laboratory.

But there was little to hold him -- or any fertility doctor -- to account, beyond professional guidelines and the statistical reports required by the federal government documenting pregnancy and birth rates.

The Centers for Disease Control and Prevention posts the reports on its website and in a book published yearly. Eight percent of the nation's 464 clinics don't report their numbers, and there is no penalty for the lapse.

Other countries take a stricter approach. In Europe, laws limit the number of embryos that can be used in a single procedure. National healthcare typically covers a certain number of IVF treatments, taking the pressure off doctors to achieve success on their first try. Birth rates are generally lower, but so are rates of multiple births.

Los Angeles Times Articles